IL22RA1 and melanoma: In melanoma, IL22RA1 mutation upregulated the expression of genes involved in the hypoxia-inducible factor-1alpha (HIF-1α) signaling pathway, whereas the metabolic pathways including biosynthesis of unsaturated fatty acids and butanoate metabolism were downregulated.